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Abstract 
Introduction: Fine needle aspiration cytology 
(FNAC) of lymph nodes is a safe, easy, cheap and quick 
diagnostic tool, which involves the examination of a 
random sample of cells from a lymph node. 
Aim: To assess the distribution of diagnostic categories 
and the efficacy of lymph node fine needle aspiration 
cytology at our institution.  These were compared to the 
literature. 
Methodology: All of lymph node FNAC cases 
taken between the 1st January 2012 and the 31st 
December 2013 were retrieved from our Laboratory 
Information System.  A total of 300 cases were retrieved 
and then placed into one of six categories; Category 1: 
Non-diagnostic, 2: Reactive, 3: Probably reactive but 
lymphoma cannot be excluded, 4: Non-Hodgkin 
lymphoma, 5: Hodgkin lymphoma, and 6: Metastasis. 
These were then correlated with the histology of the 
lymph node excision specimens. 
Results: The proportion of diagnoses placed under 
categories 1, 2, 3, 4, 5 and 6 represent 14%, 53%, 4.3%, 
5.7%, 1.7% and 21.3% of the total respectively. The 
overall efficacy of FNAC showed a sensitivity of 84.5%, 
specificity of 99.3%, a false negative rate of 10%, a false 
positive rate of 0.7%, accuracy of 93.1%, positive 
predictive value of 98.8% and negative predictive value 
of 89.9%. 
Conclusions: FNAC of lymph nodes is a very 
useful and effective tool in triaging patients with 
lymphadenopathy. 
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Introduction 
Fine needle aspiration cytology (FNAC) is a safe, 
easy, quick, cheap technique for diagnosing benign as 
well as malignant enlarged lymph nodes.1-2 This 
technique involves taking a random sample of cells from 
a potentially pathological lymph node  using a needle.3   
The indications for lymph node FNAC are: for the 
diagnosis of reactive lymphadenopathy, metastatic and 
lymphoid malignancy, staging and monitoring for 
relapse or the effects of treatment.1 Lymph node FNAC 
is excellent in the diagnosis of metastatic malignancy, 
reducing the need for diagnostic excision biopsy in 
many patients.4-5 The diagnosis of lymphoid neoplasms 
on FNAC remains controversial and is often followed by 
tissue biopsy.  
In this study, we present our lymph node FNAC 
experience encompassing all diagnostic categories.  
  
Materials and methods 
All lymph node FNAC cases taken between the 1st 
January 2012 and the 31st December 2013 were retrieved 
from our Laboratory Information System via the Cognos 
search engine by inputting the specimen type using 
SNOMED codes. The reports were then reviewed and 
categorised as follows: 
Category 1:    Non-diagnostic 
Category 2:    Benign reactive lymphoid hyperplasia 
Category 3:    Although favouring a reactive process, 
lymphoma cannot be excluded 
Category 4:    Suspicious for non-Hodgkin lymphoma 
Category 5: Suspicious for Hodgkin lymphoma 
Category 6:    Metastatic malignancy 
The cytological findings were then correlated with 
the histological findings of the lymph node excision 
specimens when these were subsequently submitted to 
the histopathology department.  The aim was to assess 
the overall efficacy of the test. 
 
Results 
A total of three hundred (300) lymph nodes were 
sampled by FNA in the period under review. The 
diagnoses designated under categories 1, 2, 3, 4, 5 and 6 
represented 14.0%, 53.0%, 4.3%, 5.7%, 1.7% and 21.3% 
of all lymph node FNACs respectively (see figure 1). 
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Figure 1: Proportion of cases in the six diagnostic Categories 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Category 1: Non Diagnostic 
In our study, 73.8% (32 out of 42) of all of cases 
categorised as non-diagnostic did not have follow up 
histology.  One case (2.38%) was followed up by core 
biopsy; however the two core biopsies submitted were 
composed of fibrous connective tissue and skeletal 
muscle with no evidence of lymphoid tissue on 
histology.  This biopsy was therefore considered 
inadequate for diagnostic purposes.  In four cases 
(9.52%), subsequent histology showed benign lymphoid 
hyperplasia. Three cases of Hodgkin lymphoma and 
three cases of metastatic carcinoma (each representing 
7.14%) were diagnosed on histology of the subsequently 
excised lymph nodes.   
These results are summarised in Table 1. 
Cases in this FNAC diagnostic category are 
inadequate and hence histologic correlation is not 
appropriate. We have therefore opted to exclude this 
category from our efficacy statistics. 
 
Category 2: Benign lymphoid hyperplasia 
In our study, 78.6% (125) of cases were not 
followed up by histology. From a clinical perspective 
and for the purpose of this study, these are assumed 
to represent reactive lymph nodes.  The 21.4% cases 
which did have subsequent histology can be divided 
into two groups, namely true negative cases (52.9%) 
and false negative cases (47.1%).  The false negative 
cases were 6 cases of non-Hodgkin lymphoma, 1 case 
of Hodgkin lymphoma and 9 cases of metastatic 
carcinoma. 
These results are summarised in Table 2. 
 
 
 
 
Category 3: Although favouring a reactive process, 
lymphoma needs to be excluded  
Six cases in this category showed benign lymphoid 
hyperplasia on subsequent histology whilst two cases 
were diagnosed as non-Hodgkin lymphoma and four 
cases as Hodgkin lymphoma on subsequent histology.  
One case did not have follow up histology. 
  The thirteen cases in this diagnostic category were 
excluded from the overall efficacy statistics in view of 
the higher degree of uncertainty inherent in the cytologic 
diagnosis.  
 
Category 4: Suspicious for non-Hodgkin lymphoma 
There were seventeen cases in this category.  Two 
cases did not have follow up histology however they 
were confirmed with ancillary tests; using cell block and 
immunohistochemistry. Fourteen cases were confirmed 
to be cases of non-Hodgkin lymphoma on follow up 
histology.  One case was a false positive and was 
diagnosed as a pilomatrixoma on subsequent histology. 
 
Category 5: Suspicious for Hodgkin lymphoma  
All five cases diagnosed on FNAC were confirmed 
on subsequent histology. 
 
Category 6: Metastatic malignancy (see Table 3) 
Of these, twenty two cases did not have a follow up 
histology.  From a clinical perspective and for the 
purpose of this study, these are assumed to represent 
metastasis to lymph nodes.  Fifteen cases were 
confirmed using ancillary tests.  Twenty seven cases 
were confirmed on subsequent histology. 
These results are summarised in Table 5. 
The overall efficacy of lymph node fine needle 
aspiration cytology is summarised in table 4. 
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Table 1: Category 1: Non Diagnostic 
 
Number of patients Histopathological report Number of patients 
42 (14%) No follow up histology 
Non diagnostic histology 
Benign lymphoid hyperplasia 
Hodgkin lymphoma 
Metastatic carcinoma 
31(74%) 
1(2%) 
4(10%) 
3(7%) 
3(7%) 
 
Table 2: Category 2: Benign Reactive Lymphoid Hyperplasia 
 
Number of patients Histopathological report Number of patients 
159 (53.0%) No follow up histology 
Benign lymphoid hyperplasia 
Non-Hodgkin Lymphoma 
Hodgkin Lymphoma 
Metastatic carcinoma 
125(79%) 
18(11%) 
6(4%) 
1(1%) 
9(5%) 
 
Table 3: Category 6: Metastatic malignancy 
 
Number of patients Histopathological report Number of patients 
64 (21.30%) No follow up histology 
Metastatic carcinoma* 
22(34%) 
42(66%) 
*Of these, 27 cases had follow up histology and 15 cases were confirmed using cell block and immunohistochemistry. 
Table 4: The overall efficacy of lymph node FNAC 
True negative 
False negative 
True positive 
False positive 
143 
16 
87 
1 
Sensitivity 
Specificity 
False positive rate 
False negative rate 
Accuracy 
Positive Predictive Value 
Negative Predictive Value 
84.5% 
99.3% 
0.7% 
10.0% 
93.1% 
98.8% 
89.9% 
 
 
18
OrO 
 
 
 
 Original Article  
 
 
Malta Medical Journal    Volume 27 Issue 03 2015                                                                                                                
 
 
Discussion 
The proportion of cases in the different categories and 
the efficacy of FNAC at our institution were compared 
to those reported in the literature (summarised in Tables 
5 and 6).  
 
Category 1: Non Diagnostic 
A non-diagnostic diagnosis occurs when the 
specimen is found unsatisfactory either because of low 
cellularity or due to difficulty in assessment e.g. 
obscuring blood.   
 
 
After a literature review, we could not find a 
standardised system for assessing the adequacy of a 
lymph node aspirate and in practice this appears to be 
based on the cytologist’s interpretation.  The adequacy 
rate of lymph node FNAC in our institution (14%) 
compares well with that reported in the literature (5.6% 
–21.7% 2, 7).    The wide variability depends on the size 
and location of the lymph node, and on the operator’s 
and cytologist’s experience.  
 
 
 
 
Table 5: Comparison of the relative frequency of the different categories 
 
 C1 C2 C3 C4 C5 C6 
Our results 14% 53% 4.3% 5.7% 1.8% 21.3% 
Mitra et al 5.6% - 2.8% 13.7% 
Nasuti et al 12% 13%  17% 52% 
Gilani et al 21.7% - - - - - 
Jing et al 8% - - - - - 
Steel et al 10.9%      
Rammeh et al 20.6%  - - - - - 
Lioe et al 15.9% 52.7% 6.1% 25.1% 
Stani J - 23.5% - - - - 
 
Table 6: Comparison of the efficacy of fine needle aspiration cytology of lymph nodes 
 
 Sensitivity Specificity False 
negative 
False 
positive 
Accuracy Positive 
Predictive 
Value 
Negative 
Predictive 
Value 
Our results 84.5% 99.3% 10% 0.7% 93.1% 98.8% 89.9% 
Gilani et al 91.7% 100% 4.3% 1 11% 2 93.5% 100% 77.8% 
Jing et al (for 
metastasis) 
77.5% 100% - - 82.2% 100% 53.7% 
Steel et al - - 3.4% 0.9% - - - 
Thierauf et al 85% 87% 5% 15% - 64% 92% 
Hall et al (for 
melanoma) 
97% 98% - - - - - 
Lioe et al 85.4% 100% 12.5% 3 0% 94.4% 100% 91.8% 
Marti et al (for 
metastasis) 
86% 100% 29% 0% 91% 100% 78% 
Fung et al (for 
metastasis) 
75% 100% - - 95.6%% 100% 79% 
1 Micrometastasis on histology. 
2 The patients had undergone preoperative neoadjuvant chemotherapy, with no residual tumour present. 
3 The false negative rate fell to 3.5% after excluding lymphomas. 
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Category 2: Benign lymphoid hyperplasia 
A diagnosis of benign lymphoid hyperplasia is 
conferred when the cytology specimen is cellular, is not 
obscured by blood or other material and is composed of 
a polymorphic population of lymphoid cells.  The 
proportion of cases in this category in our institution is 
considerable, amounting to 53% of all cases.  This is 
higher than reported by Nasuti et al and Stani (13% and 
23.5% respectively) 6,  15, and comparable to Lioe et al 
(52.7%). 14 The high percentage of cases in category 2 in 
this study could possibly be accounted for by a lower 
clinical threshold to perform fine needle aspiration 
cytology at our institution. 
 
Category 3: Although favouring a reactive process, 
lymphoma needs to be excluded 
In this category, the cytological picture is cellular 
and unobscured and is composed of a relatively 
monomorphic population of small to intermediate-sized 
lymphocytes.  This category is reserved for those cases 
where the cytological picture is equivocal and has 
overlapping features.  One of the limitations of fine 
needle aspiration cytology of lymph nodes is in 
differentiating between reactive lymphoid proliferations 
and lymphoma, especially low grade lymphoma.5 The 
proportion of cases in this category (4.3%) lies in 
between that observed in the study by Mitra et al (2.8%) 
and Lioe et al (6.1%).2, 14   
 
Category 4: Suspicious or diagnostic of non-Hodgkin 
lymphoma 
The cytological picture of this category is 
characterised by a cellular, unobscured monomorphic 
population of intermediate-sized to large atypical 
lymphoid cells and with variable mitosis.  At our 
institution, non-Hodgkin lymphoma holds an overall 
specificity of 94.1% and sensitivity of 66.7%. This rises 
to 72.7% if the cases in categories 1 and 3 are excluded.   
 
Category 5: Suspicious for Hodgkin lymphoma 
In this category, the diagnosis relies on the 
identification of Reed-Sternberg or Hodgkin cells, on a 
background of small monomorphic lymphocytes, 
eosinophils and other inflammatory cells, in the absence 
of tingible body macrophages.  At our institution, 
Hodgkin lymphoma holds a specificity of 100% and 
sensitivity of 38%. If the cases in categories 1 and 3 are 
excluded, the sensitivity rises to 83%.  According to 
Chhieng et al.10, Hodgkin lymphoma has a high false 
negative rate due to typical scarcity of Reed-Sternberg 
or Hodgkin cells in aspirates, the presence of fibrosis (in 
the nodular sclerosis type), sampling error and 
misinterpretation of the diagnostic cells. 
 
Category 6: Metastatic malignancy 
In this category, the cytological diagnosis relies on 
the presence of single cells or clusters of malignant cells 
with a morphology which is alien to that of the normal 
lymphoid milieu.  This often occurs on a background of 
a normal lymphoid FNAC specimen.  The overall 
specificity at our institution was 100%.  The overall 
sensitivity was 84%, which rises to 88% after excluding 
the cases in categories 1 and 3.  Our data compares well 
with that in the reported literature which shows a 
specificity of 100% across all studies and a sensitivity 
which ranges from 75 to 86%.8, 16-17 The lower 
specificity in some cases can be explained by the small 
size of metastatic deposits. 17 
There overall efficacy of lymph node fine needle 
aspiration cytology is tabulated in table 4. 
 
This study has a number of limitations which were 
taken into consideration: 
 This is a retrospective study. 
 A number of lymph node FNAC cases were 
submitted by the clinicians as a lesion or mass in 
the head and neck region.  These were thus encoded 
using the ‘Head and neck cytologic material’ 
SNOMED code and were not included in this study. 
 This study assumed that all lymph nodes classified 
as benign reactive lymphoid hyperplasia, which did 
not have a subsequent diagnosis of lymphoma 
within one year, were truly reactive. 
 This study assumed that all lymph nodes classified 
as metastatic malignancy were truly involved. 
 Lymph node excisions performed in the private 
sector following a FNA performed at our institution 
could not be assessed. 
 The lymph node excised may not be the same 
lymph node that was sampled by fine needle 
aspiration. 
 The numbers in categories 3,4,5 are small. These 
can introduce a wide margin of error in statistical 
comparisons. 
In spite of these limitations, this study has been able 
to demonstrate the clinical usefulness of this test. 
 
Conclusion 
The overall efficacy of lymph node FNAC 
diagnosis compares very well with that quoted in the 
literature.  This test’s greatest strength lies in triaging 
reactive from neoplastic lymph nodes, principally high 
grade non-Hodgkin’s lymphoma and metastasis.  Its 
weakness lies in sampling issues and differentiating 
between certain patterns of reactive lymphoid 
hyperplasia and low grade non-Hodgkin’s lymphoma. 
Our comparatively high rate of cases in the benign 
category could possibly be explained by a higher index 
of suspicion among our clinicians with a consequent 
lower threshold to biopsy.  The proportion of cases with 
a non-diagnostic cytology result could be possibly 
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brought down by ensuring that operators and cytologists 
are properly trained and retrained.  Fine needle 
aspiration cytology of lymph nodes remains a very 
important and valid tool in the management of patients 
with lymphadenopathy. 
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